September 21, 2014 2:18 AM ET

Biotechnology

Company Overview of Cibus Global, Ltd.

Company Overview

Cibus Global, Ltd. develops precision gene editing systems for agricultural, industrial lubricants, food ingredients, and health care markets worldwide. The company focuses on the development of industrial biotechnology, agriculture, and human health and wellness solutions. It offers Rapid Trait Development System (RTDS), a precision gene editing technology that is used to develop new and beneficial characteristics by modifying cell function; Squalane, a clear oil compound that is used in cosmetics, pharmaceuticals, and specialty lubricants; Ergosterol, a natural sterol, which is found in yeast and fungal species; and RTDS illustrations that are scientific documents and available for reprint...

6455 Nancy Ridge Drive

Suite 100

San Diego, CA 92121

United States

Founded in 2001

Phone:

858-450-0008

Key Executives for Cibus Global, Ltd.

Chief Executive Officer and President
Senior Vice President
Senior Vice President of Research & Development
Head of the Cell Biology Department
Vice President of International Development
Compensation as of Fiscal Year 2014.

Cibus Global, Ltd. Key Developments

Cibus Global Announces Executive Changes

Keith Walker, Ph.D., who has led Cibus Global since the company was founded in 2001, has announced his retirement. Rapid Trait Development System developer, and company's Sr. VP of Research and Development Peter Beetham has been tapped to take the top position at the precision gene editing firm. Walker has been named to the Cibus Board of Directors. Dr. Beetham has led the development of the company's core technologies in gene editing that have driven the company's expansion to more than 100 employees with over 70 scientists focusing on advancing company's patented and gene editing technologies. Greg Gocal, Ph.D., the current Vice President of Research at the company, also a member of the founding group has been promoted to Senior Vice President of Research and Development to oversee all research activities at the company. Dr. Gocal, prior to joining the company held research positions and headed the molecular biology group at Valigen.

Cibus Global Appoints Keith Walker as CEO and President

Cibus Global announced that Keith Walker, Ph.D., has been appointed as CEO and President. Dr. Walker has held the position of President since the company was founded in 2001. Prior to Cibus, Dr. Walker held a variety of management positions at the Mycogen Corporation, ranging from business development, biotechnology research management and technology in-and-out-licensing.

Similar Private Companies By Industry

Company Name Region
AbVitro, Inc. United States
MuciMed, Inc. United States
Presage Biosciences, Inc. United States
Star Biologics, Inc. United States
BioControl Systems, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 16, 2014
--
Merger/Acquisition
January 6, 2014
Nucelis Inc.
Private Placement
October 10, 2013
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Cibus Global, Ltd., please visit www.cibus.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.